Literature DB >> 24603462

Disturbed balance between serum levels of receptor tyrosine kinases Tie-1, Tie-2 and angiopoietins in systemic sclerosis.

Zofia Gerlicz1, Bozena Dziankowska-Bartkowiak, Elzbieta Dziankowska-Zaborszczyk, Anna Sysa-Jedrzejowska.   

Abstract

OBJECTIVE: The aim of this study was to determine the characteristic factors for vascular development and maintenance levels as well as correlation between Tie-1 receptors, Tie-2 receptors and the corresponding ligands--angiopoietins--in systemic sclerosis (SSc) patients.
MATERIALS AND METHODS: Serum levels of Tie-1, Tie-2, Ang-1 and Ang-2 were measured in 25 SSc patients and healthy controls.
RESULTS: There was a statistically significant difference in serum Tie-1 (p = 0.009) and Ang-2 (p = 0.001) levels in SSc patients compared with healthy controls. Significant correlations between Tie-1 and Tie-2 (ρ = 0.70, p = 0.0001) and between Tie-1 and Ang-2 (ρ = -0.92, p = 0.002) were found in the SSc group. Serum levels of Tie-2 were positively associated with esophagus changes (U = 2.03, p = 0.041) and Ang-1 was negatively correlated with duration of Raynaud's phenomenon (ρ = -0.75, p = 0.00008).
CONCLUSION: The increase in serum concentration of Tie-1 and Ang-2 in patients with SSc may confirm a molecular imbalance between receptor tyrosine kinases Tie and their ligands.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24603462     DOI: 10.1159/000357806

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  6 in total

Review 1.  Therapeutic targeting of the angiopoietin-TIE pathway.

Authors:  Pipsa Saharinen; Lauri Eklund; Kari Alitalo
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

2.  Circulating angiostatin serum level in patients with systemic sclerosis.

Authors:  Zofia Gerlicz-Kowalczuk; Elzbieta Dziankowska-Zaborszczyk; Bożena Dziankowska-Bartkowiak
Journal:  Postepy Dermatol Alergol       Date:  2017-12-31       Impact factor: 1.837

3.  Tie2 as a novel key factor of microangiopathy in systemic sclerosis.

Authors:  Falk Moritz; Janine Schniering; Jörg H W Distler; Renate E Gay; Steffen Gay; Oliver Distler; Britta Maurer
Journal:  Arthritis Res Ther       Date:  2017-05-25       Impact factor: 5.156

4.  Novel classification for global gene signature model for predicting severity of systemic sclerosis.

Authors:  Zariel I Johnson; Jacqueline D Jones; Angana Mukherjee; Dianxu Ren; Carol Feghali-Bostwick; Yvette P Conley; Cecelia C Yates
Journal:  PLoS One       Date:  2018-06-20       Impact factor: 3.240

Review 5.  Management of Endothelial Dysfunction in Systemic Sclerosis: Current and Developing Strategies.

Authors:  Djúlio César Zanin-Silva; Maynara Santana-Gonçalves; Marianna Yumi Kawashima-Vasconcelos; Maria Carolina Oliveira
Journal:  Front Med (Lausanne)       Date:  2021-12-22

6.  ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis.

Authors:  Zofia Gerlicz-Kowalczuk; Jolanta D Torzecka; Elżbieta Dziankowska-Zaborszczyk; Alicja Ograczyk; Anna M Zalewska-Janowska; Anna Woźnicka; Bożena Dziankowska-Bartkowiak
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.